¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"combined aphasia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·º´
  • subacute combined degeneration
    ¾Æ±Þ¼º¿¬ÇÕº¯¼º
  • severe combined immunodeficiency disease
    ÁßÁõº¹Çո鿪°áÇ̺´
  • anomic aphasia
    ¸íξð¾î»ó½ÇÁõ, ¸íĪ½Ç¾îÁõ
  • anosmic aphasia
    Èİ¢¾ð¾î»ó½ÇÁõ, Èİ¢½Ç¾îÁõ
  • aphasia
    ¾ð¾î»ó½ÇÁõ, ½Ç¾îÁõ
  • auditory aphasia
    û°¢¾ð¾î»ó½ÇÁõ, û°¢½Ç¾îÁõ
  • ageusic aphasia
    ¹Ì°¢¾ð¾î»ó½ÇÁõ, ¹Ì°¢½Ç¾îÁõ
  • amnesic aphasia
    °Ç¸Á¾ð¾î»ó½ÇÁõ, °Ç¸Á½Ç¾îÁõ
  • amnestic aphasia
    °Ç¸Á¾ð¾î»ó½ÇÁõ, °Ç¸Á½Ç¾îÁõ
  • complete aphasia
    ¿ÏÀü¾ð¾î»ó½ÇÁõ, ¿ÏÀü½Ç¾îÁõ
  • conduction aphasia
    Àüµµ¾ð¾î»ó½ÇÁõ, Àüµµ½Ç¾îÁõ
  • central aphasia
    ÁßÃß¾ð¾î»ó½ÇÁõ, ÁßÃ߽ǾîÁõ
  • expressive aphasia
    Ç¥Çö¾ð¾î»ó½ÇÁõ, Ç¥Çö½Ç¾îÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • combined modality therapy
    º´¿ë¿ä¹ý
  • combined plantar sign
    ¿¬Çչ߹ٴÚ¡ÈÄ
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·Áõ, º¹ÇÕÆÇ¸·º´
  • combined ventricular hypertrophy
    º¹ÇսɽǺñ´ë
  • subacute combined degeneration
    ¾Æ±Þ¼º¿¬ÇÕº¯¼º
  • aphasia
    ¾ð¾î»ó½ÇÁõ
  • ageusic aphasia
    ¹Ì°¢¾ð¾î»ó½ÇÁõ
  • amnestic aphasia
    ±â¾ï¾ð¾î»ó½ÇÁõ
  • anosmic aphasia
    Èİ¢¾ð¾î»ó½ÇÁõ
  • auditory aphasia
    û°¢¾ð¾î»ó½ÇÁõ
  • central aphasia
    ÁßÃß¾ð¾î»ó½ÇÁõ
  • complete aphasia
    ¿ÏÀü¾ð¾î»ó½ÇÁõ
  • conduction aphasia
    Àüµµ¼º¾ð¾î»ó½ÇÁõ
  • expressive aphasia
    Ç¥Çö¾ð¾î»ó½ÇÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • aphasia, ataxic
    ½ÇÁ¶¼º ½Ç¾îÁõ
  • aphasia, auditory
    û°¢¼º ½Ç¾îÁõ
  • aphasia, conduction
    Àüµµ¼º ½Ç¾îÁõ
  • aphasia, expressive
    Ç¥Çö½Ç¾îÁõ
  • aphasia, fluent
    À¯Ã¢¼º ½Ç¾îÁõ
  • aphasia, gibberish
    Ⱦ¼³¼ö¼³ ½Ç¾îÁõ
  • aphasia, global
    Àü(îï)½Ç¾îÁõ
  • frontocortical aphasia
    ÀüµÎ¿±ÇÇÁú¼º ½Ç¾îÁõ(îñÔéç¨ù«òõàõã÷åÞñø).
  • frontolenticular aphasia
    ¿îµ¿ÁßÃß¼º ½Ç¾îÁõ(ê¡ÔÑñéõÒàõã÷åÞñø), ÀüµÎ·»ÁîÇÙ ¼º ½Ç¾îÁõ.
  • functional aphasia
    ±â´É¼º ½Ç¾î(Áõ).
  • global aphasia
    Àü½Ç¾îÁõ(îïã÷åÞñø).
  • global aphasia
    Àü½Ç¾îÁõ
  • graphomotor aphasia
    ¼­Àڿ¼º ½Ç¾îÁõ(ßöí®ê¡ÔÑàõã÷åÞñø).
  • hereditary aphasia
    À¯Àü(¼º) ½Ç¾î(Áõ).
  • posterior group of aphasia
    ÈĺνǾ(ý­Ý»ã÷åÞÏØ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • combined immunodeficiency syndrome
    º¹ÇÕÇü ¸é¿ª°áÇÌ ÁõÈıº
  • combined immunodeficiency syndrome
    º¹ÇÕÇü¸é¿ª°áÇÌÁõ(Èıº)
  • combined impression
    ¿¬ÇÕÀλó(æáùêìÔßÚ).
  • combined manual reposition
    ½ÖÇÕ¿ë¼öȯ³³¹ý(äªùêéÄâ¢ü½Ò¡Ûö).
  • combined modality therapy
    º´¿ëÄ¡·á¹ý
  • combined neck dissection
    Àϰý¼º °æºÎȮû¼ú(Àϰý¼º ºÎȮû¼ú).
  • combined nevus
  • combined nystagmus
    º¹ÇÕ¾ÈÁø
  • combined pelvimetry
    º¹ÇÕ¼º °ñ¹Ý°èÃø¹ý.
  • combined plantar sign
    ¿¬ÇÕ¼º Á·Àú¡ÈÄ(æáùêàõðëî¼ó£ý¦).
  • combined podalic version
    º¹ÇÕ¼º Á·ºÎÀÌ¿ëȸÀü¼ú, ½ÖÇÕÁ·À§È¸Àü¼ú.
  • combined scintiscan
    º´Çսů¼½ºÄµ.
  • combined sclerosis
    º´ÇÕ°æÈ­Áõ(ܱùê Ìãûùñø).
  • combined sewer
    ÇÕ·ù½Ä Çϼö±¸(̰ËôËà ̰ËàË´).
  • combined system disease
    º¹ÇÕ°èÅëÁúȯ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BDAE Boston Diagnostic Aphasia Examination
FAST flow-assisted, short-term [balloon catheter]; fluorescent antibody staining technique; fluoro-allerg...
HAT Halsted Aphasia Test; head, arm, trunk; heparin-associated thrombocytopenia; heterophil antibody tit...
MASA Medical Association of South Africa; mental retardation-aphasia-shuffling gait-adducted thumbs [synd...
MLAB Multilingual Aphasia Battery
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CAB Combined androgen blockade
CCT Combined cortical thickness
CHL Combined hyperlipidemia
CID Combined immunodeficiency
COC Combined oral contraceptive
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • insulin convulsive therapy combined
    Àν¶¸° °æ·Ã º´ÇÕ Ä¡·á, Àν¶¸° °æ·Ã º´ÇÕ ¿ä¹ý
  • severe combined immunodeficiency
    ÁßÁõ º¹ÇÕ ¸é¿ª °áÇÌÁõ, ÁßÁõ È¥ÇÕ ¸é¿ª °áÇÌÁõ
  • ageusic aphasia
    ¹Ì°¢¼º ½Ç¾î
    ¹Ì°¢¿¡ °üÇØ ¸»·Î Ç¥ÇöÇÏ´Â ÈûÀ» »ó½ÇÇÑ °Í.
  • amnemonic aphasia
    °Ç¸Á½Ç¾î
    ½Ç¾îÁõÀÇ °á°ú·Î¼­ »ý±â´Â ¾ð¾îÀÇ °Ç¸ÁÁõ.
  • anosmic aphasia
    Èİ¢¼º ½Ç¾î
    Èİ¢¿¡ °üÇÏ¿© ¸»·Î Ç¥ÇöÇÒ ¼ö ¾ø´Â °Í.
  • aphasia
    ½Ç¾î, ½Ç¾îÁõ
    1. ¸», ±Û, Áö½ÃÇÏ´Â µîÀÇ Ç¥Çö·Â, ¶Ç´Â ¾ð¾îÀÇ ÀÌÇØ·ÂÀÌ »ó½ÇµÈ »óÅÂ. ³ú ÁßÃßÀÇ »óÇØ³ª Áúȯ¿¡ ÀÇÇÏ¿© ¹ß»ýÇÑ´Ù. 2. ´ë³úÀÇ ¼Õ»ó¿¡ ÀÇÇØ ¾î¸± ¶§ºÎÅÍ ½ÀµæÇÑ ¾ð¾îÀÇ Ç¥Çö ¶Ç´Â ÀÌÇØ°¡ Àå¾ÖµÇ´Â »óÅÂ. ´Ü¼øÈ÷ ½Ç¾î¶ó°íµµ ÇÑ´Ù. ±¸¾îÀå¾Ö¿Í´Â ´Þ¸®, ¹ß¾îÇÏ´Â ±ÙÀ°Àº Á¤»óÀÌÁö¸¸ ¾ð¾î ÁßÃß¿¡ Àå¾Ö°¡ À־ ÀϾ ¾ð¾îÀå¾ÖÀÌ´Ù. ¾ð¾î ÁßÃß´Â ´ëºÎºÐÀÌ ¿ÞÂÊÀÇ ´ë³ú ¹Ý±¸¿¡ Àֱ⠶§¹®¿¡, ³ë³â±â¿¡ ¸¹Àº ³ú ÃâÇ÷À̳ª ³ú ¿¬È­·Î ÀÎÇØ ¿À¸¥ÂÊ ¼öÁ·¿¡ ¸¶ºñ¸¦ ÀÏÀ¸Ä×À» ¶§ ½Ç¾îÁõÀ» ÀÏÀ¸Å°´Â °æ¿ì°¡ ¸¹´Ù. ¿îµ¿¼º°ú °¨°¢¼ºÀ¸·Î ³ª´«´Ù. ¿îµ¿¼º ½Ç¾îÁõÀº ÀÚ½ÅÀÌ ¹ß¾î´Â ÇÏÁö ¸øÇÏÁö¸¸, »ç¶÷µéÀÌ ÇÏ´Â ¸»Àº ÀÌÇØµÇ´Â °ÍÀ¸·Î¼­ ÈÆ·Ã¿¡ ÀÇÇÏ¿© Á¡Â÷ ȸº¹µÈ´Ù. °¨°¢¼º ½Ç¾îÁõÀº ¿µ¾î¸¦ ¸ð¸£´Â »ç¶÷¿¡°Ô ¿µ¾î·Î À̾߱âÇÏ´Â °Í°ú °°Àº °ÍÀ¸·Î¼­, ¹ß¾î´Â ÇÒ ¼ö ÀÖÀ¸³ª À̾߱⸦ ÀÌÇØÇÏÁö ¸øÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. ÀÌ °æ¿ì´Â ȸº¹ÀÌ °ï¶õÇÑ °æ¿ì°¡ ¸¹´Ù. 3. ¹ß¼º¿¡ °ü¿©ÇÏ´Â ´Ù¸¥ ¸»Ãʱâ°üÀÇ ÀÌ·¸´ÙÇÒ °áÇÔÀÌ ¾øÀÌ ´ë³ú ÇÇÁúÀÇ ¼Õ»óÀ¸·Î ÀϾ´Â ¾ð¾îÀå¾Ö.
  • associative aphasia
    ¿¬ÇÕ¼º ½Ç¾î
    ÁßÃß ±â±¸¸¦ ±¸¼ºÇÏ´Â ºÎÀ§°£ÀÇ ¿¬¶ôÀå¾Ö¿¡ ÀÇÇÑ ½Ç¾îÁõ.
  • auditory aphasia
    û°¢¼º ½Ç¾î
    ³úÀÇ Ã»°¢ ÁßÃß Áúȯ¿¡ ÀÇÇÑ ½Ç¾îÁõ.
  • Brocas aphasia
    ºê·ÎÄ« ½Ç¾îÁõ
  • central aphasia
    ÁßÃß¼º ½Ç¾îÁõ
  • commissural aphasia
    ±³·Ã¼º ½Ç¾î
    ¿îµ¿°ú °¨°¢ÀÇ ¾ð¾î ÁßÃß°£ ¿¬¶ô·Î¸¦ Àå¾ÖÇÏ´Â º´º¯¿¡ ÀÇÇÑ ½Ç¾îÁõ.
  • complete aphasia
    ¿ÏÀü ½Ç¾îÁõ
    ¸ðµç ¾ð¾î ÁßÃßÀÇ º´º¯¿¡ ÀÇÇÑ ½Ç¾îÁõ. ¾î¶°ÇÑ ¹æ¹ýÀ¸·Îµµ ŸÀΰú Àǻ縦 ¼ÒÅëÇÒ ¼ö ¾ø°Ô µÇ´Â °Í.
  • conduction aphasia
    Àüµµ¼º ½Ç¾î
    ¸»ÇÑ ¾ð¾î¸¦ Á¤»óÀûÀ¸·Î ÀÌÇØÇÏÁö¸¸ ´Ü¾î¸¦ Á¤È®È÷ º¹Ã¢ÇÒ ¼ö ¾ø´Â ½Ç¾îÁõ.
  • developmental aphasia
    ¹ß´Þ¼º ½Ç¾îÁõ
  • fluent aphasia
    ´Þº¯ ½Ç¾î
    ¸»ÀÇ ±¸¼ºÀº Á¤´çÇÏ°í ¹®¹ýÀûÀ¸·Îµµ Á¤È®Çϳª ¸»ÀÇ Àǹ̰¡ °á¿©µÈ ½Ç¾îÁõ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
combined version Bipolar version by means of one hand in the vagina, the other on the abdominal wall.
(05 Mar 2000)
congenital severe combined immunodeficiency Disease, one form of which is caused by the lack of a transcription factor required for expression of HLA class II genes.
(18 Nov 1997)
contraceptives, oral, combined Fixed drug combinations administered orally for contraceptive purposes.
(12 Dec 1998)
severe combined immunodeficiency Group of rare congenital disorders characterised by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an x-linked or autosomal recessive defect. About half of the patients with autosomal recessive scid are deficient in the enzyme adenosine deaminase.
(12 Dec 1998)
severe combined immunodeficient mice Mice that lack both T and B lymphocytes and are used for transplantation and study of human lymphoid tissues resulting in a SCID-human mouse chimera.
See: severe combined immunodeficiency.
(05 Mar 2000)
hyperlipidemia, familial combined A disorder genetically distinct from the other inherited hyperlipidemias characterised by the type II or type IV lipoprotein pattern (the pattern may change from time to time and the lipid level may be normal at one time and abnormal at another time).
(12 Dec 1998)
subacute combined degeneration of the spinal cord A subacute or chronic disorder of the spinal cord, such as that occurring in certain patients with vitamin B12 deficiency, characterised by a slight to moderate degree of gliosis in association with spongiform degeneration of the posterior and lateral columns.
Synonym: combined sclerosis, combined system disease, funicular myelitis, Putnam-Dana syndrome, vitamin B12 neuropathy.
(05 Mar 2000)
the combined tendinous expansions of the sartorius Gracilis, and semitendinosus muscles at the medial border of the tuberosity of the tibia.
(05 Mar 2000)
familial combined hyperlipemia familial hyperlipoproteinemia
familial combined hyperlipidaemia <biochemistry, endocrinology> Inherited as a defective gene, this disorder is characterised by elevations in serum cholesterol and/or triglycerides.
There are often multiple types of lipoproteins (LDL) elevated in one family. This condition is associated with an increased risk of cardiovascular disease.
(27 Sep 1997)
acoustic aphasia An impairment in comprehension of the auditory forms of language and communication, including the ability to write from dictation in the presence of normal hearing. Spontaneous speech, reading, and writing are not affected.
Synonym: acoustic aphasia, word deafness.
(05 Mar 2000)
acquired epileptic aphasia <syndrome> Acquired epileptic aphasia. The typical history is that of a child whose development is normal for several years and then, either suddenly or in a fluctuating manner, loses comprehension of speech and the ability to use speech to communicate. The seizures are of no specific type, and are mostly mild and infrequent partial or atypical absences.
(12 Dec 1998)
amnesic aphasia An aphasia in which the principal deficit is difficulty in naming persons and objects seen, heard, or felt; due to lesions in various portions of the language area.
Synonym: amnestic aphasia, amnesic aphasia, anomia, anomic aphasia.
(05 Mar 2000)
anomic aphasia An aphasia in which the principal deficit is difficulty in naming persons and objects seen, heard, or felt; due to lesions in various portions of the language area.
Synonym: amnestic aphasia, amnesic aphasia, anomia, anomic aphasia.
(05 Mar 2000)
anterior aphasia A type of aphasia in which there is a deficit in speech production or language output, often accompanied by a deficit in communicating by writing, signs, etc. The patient is aware of his impairment.
Synonym: anterior aphasia, ataxic aphasia, Broca's aphasia, expressive aphasia, nonfluent aphasia.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á